<- Go Home

Merrimack Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Market Cap

$223.7M

Volume

79.1K

Cash and Equivalents

$234.2M

EBITDA

N/A

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

N/A

Profit Margin

N/A

52 Week High

$15.89

52 Week Low

$11.53

Dividend

N/A

Price / Book Value

0.99

Price / Earnings

-161.29

Price / Tangible Book Value

0.99

Enterprise Value

-$20.4M

Enterprise Value / EBITDA

N/A

Operating Income

-$2.3M

Return on Equity

1.12%

Return on Assets

-1.07

Cash and Short Term Investments

$244.1M

Debt

N/A

Equity

$221.7M

Revenue

N/A

Unlevered FCF

$21.0M

Sector

Biotechnology

Category

N/A

Company Stock Pitches